Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)

医学 腹膜后淋巴结清扫术 卡铂 临床终点 精原细胞瘤 生殖细胞肿瘤 四分位间距 外科 淋巴结 放射治疗 揭穿 化疗 内科学 睾丸癌 随机对照试验 癌症 卵巢癌 顺铂
作者
Andreas Hiester,Yue Che,Achim Lusch,Oliver Kuß,Günter Niegisch,Anja Lorch,Christian Arsov,Peter Albers
出处
期刊:European Urology [Elsevier BV]
卷期号:84 (1): 25-31 被引量:73
标识
DOI:10.1016/j.eururo.2022.10.021
摘要

Primary retroperitoneal lymph node dissection (RPLND) for clinical stage (CS) IIA/B seminoma without adjuvant treatment is an experimental treatment to avoid radiotherapy- or chemotherapy-related toxicity from standard treatment. The PRIMETEST trial aimed to prospectively evaluate the oncological efficacy and surgical safety of primary RPLND. PRIMETEST is a single-arm, single-center prospective phase 2 trial. Patients with seminoma, unilateral retroperitoneal lymph node metastases <5 cm, and human chorionic gonadotropin levels <5 mU/ml were included. Patients with CS IIA/B seminoma at initial diagnosis, and recurrence under active surveillance or following adjuvant carboplatin for CS I disease were eligible. Unilateral open or robot-assisted primary RPLND was performed. The primary endpoint of the study was progression-free survival (PFS) after 36 mo. The trial was considered positive if <30% of patients experienced a recurrence. Between 2016 and 2021, 33 patients were accrued (nine with primary CS IIA/B, 19 recurrences during active surveillance, and five recurrences following adjuvant carboplatin). Thirteen and 20 patients had CS IIA and IIB, respectively. Open and robot-assisted RPLND procedures were performed in 14 (42%) and 19 (58%) patients, respectively. After a median follow-up of 32 mo (interquartile range 23–46), ten recurrences were detected (30%, 95% confidence interval: 16–49%); thus, the primary endpoint was not met. Infield recurrences occurred in three of ten patients. The current analysis of risk factors could not identify the predictors of recurrence. Three of 33 patients (9%) presented with pN0. The PRIMETEST trial did not meet its primary endpoint. Nevertheless, PFS of 70% after a median follow-up of 32 mo suggests this approach to be of interest for highly selected patients. Selection criteria, however, need to be defined and validated in a larger prospective cohort of patients. Until then, surgery alone for the treatment of patients with CS IIA/B seminoma cannot be recommended outside of a clinical trial setting. In this study, we investigated primary surgery as an alternative to conventional treatment (chemotherapy or radiation therapy) in patients with metastatic seminoma. The primary objective of the study, to prevent at least 30% of patients from recurrence, was not met. However, certain patients may benefit from this approach and thereby avoid chemotherapy or radiation therapy. Predictive factors need to be analyzed to better select patients for this surgery-only approach.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
OK给tony的求助进行了留言
刚刚
十个勤天完成签到,获得积分10
刚刚
小二郎的应助被张煜禾采纳,获得10
刚刚
12581发布了新的文献求助10
刚刚
优美煎蛋发布了新的文献求助10
刚刚
iuwallace发布了新的文献求助10
1秒前
milion完成签到,获得积分10
1秒前
1秒前
1秒前
YitingW发布了新的文献求助10
1秒前
1秒前
研友_nVj3yn发布了新的文献求助10
1秒前
斯文败类的应助被chuhan采纳,获得10
1秒前
gela发布了新的文献求助10
2秒前
bkagyin的应助被我爱玩原神采纳,获得10
2秒前
汉堡包的应助被Ma采纳,获得10
2秒前
Ava的应助被wu采纳,获得10
2秒前
李元发布了新的文献求助10
2秒前
zzl发布了新的文献求助10
3秒前
Maestro_S的应助被职克琪采纳,获得10
3秒前
隐形曼青的应助被职克琪采纳,获得10
3秒前
3秒前
zxy发布了新的文献求助10
3秒前
甜美的兔子完成签到,获得积分10
4秒前
4秒前
accepted完成签到,获得积分10
4秒前
传奇3的应助被愤怒的水壶采纳,获得10
4秒前
SciGPT的应助被lawliet采纳,获得10
4秒前
小零完成签到,获得积分10
4秒前
Maestro_S的应助被h11采纳,获得10
4秒前
jhlllllll发布了新的文献求助10
4秒前
董文强发布了新的文献求助10
5秒前
5秒前
5秒前
清风明月发布了新的文献求助10
5秒前
迷了路的猫完成签到,获得积分10
6秒前
6秒前
jonghuang发布了新的文献求助10
9秒前
赘婿的应助被window1000采纳,获得10
9秒前
贤君发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164445
求助须知:如何正确求助?哪些是违规求助? 9558283
关于积分的说明 21744871
捐赠科研通 7754979
什么是DOI,文献DOI怎么找? 3428582
关于科研通互助平台的介绍 2553119
邀请新用户注册赠送积分活动 2473142